[Form 4] Amcor plc Insider Trading Activity
Deborah Rasin, General Counsel of Amcor plc (AMCR), reported multiple Section 16 transactions dated 09/15/2025. The Form 4 shows a disposition of 8,628 ordinary shares and the acquisition of several equity awards: 16,919 restricted stock units (RSUs) that represent contingent rights to one share each, 574,258 employee stock options with an exercise price of $8.28 (exercisable 09/15/2028 and expiring 09/15/2035), and an additional 35,024 RSUs that vest ratably on each of the first three anniversaries of the grant date. The Form indicates all reported derivative and non-derivative holdings are held directly. The filing is signed by an attorney-in-fact on 09/17/2025.
- Significant long-term incentive grants (574,258 options and RSUs) align executive pay with shareholder value over multiple years
- Options have a clear exercise price and long term ($8.28 exercise price; exercisable 09/15/2028; expiring 09/15/2035), supporting retention
- Disposition of 8,628 ordinary shares was reported; the filing does not state the reason for the sale
- Some RSU vesting details are partially unspecified in dates for one tranche (document uses a parenthetical note instead of exact exercisability dates)
Insights
TL;DR: Officer sold a small block of shares and received a sizable option grant plus RSUs, increasing long-term equity exposure.
The filing documents a disposition of 8,628 ordinary shares and the grant of large equity incentives: 574,258 options at $8.28 exercisable in 2028 (expiring 2035) and two RSU awards totaling 52, - (Note: the document lists 16,919 and 35,024 RSUs for 52, - which together equal 52, - actually 52, -; please refer to the filing for exact totals). These grants are typical for senior executives and align compensation with long-term share performance given multi-year vesting and long option term. The transaction is material to insider ownership dynamics but does not convey company-wide financial performance.
TL;DR: The filing documents standard executive compensation grants and a small share sale; governance implications are routine.
The reported awards include time-based RSUs and long-dated options, with explicit vesting/exercise dates. The RSUs include a tranche that vests ratably over three years, and options have a multiyear exercisability window, which is consistent with retention-oriented packages. The single-line disposition of 8,628 shares is documented separately from the grants and is recorded as a direct sale. No amendments, related-party purchases, nor hedging arrangements are disclosed.